BMRN
$57.18-2.16%
as of close, Oct 2, 2026
☾ AH $57.18 -2.16%
BioMarin Pharmaceutical Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.01%
BioMarin Pharmaceutical Inc. returns by year
As of market close, Oct 2, 2026
BioMarin Pharmaceutical Inc. returns by year (2000–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $59.43 | $57.18 | 0.0% | -3.8% | |
| 2025 | $65.73 | $59.43 | 0.0% | -9.6% | |
| 2024 | $96.42 | $65.73 | 0.0% | -31.8% | |
| 2023 | $103.49 | $96.42 | 0.0% | -6.8% | |
| 2022 | $88.35 | $103.49 | 0.0% | +17.1% | |
| 2021 | $87.69 | $88.35 | 0.0% | +0.8% | |
| 2020 | $84.55 | $87.69 | 0.0% | +3.7% | |
| 2019 | $85.15 | $84.55 | 0.0% | -0.7% | |
| 2018 | $89.17 | $85.15 | 0.0% | -4.5% | |
| 2017 | $82.84 | $89.17 | 0.0% | +7.6% | |
| 2016 | $104.76 | $82.84 | 0.0% | -20.9% | |
| 2015 | $90.40 | $104.76 | 0.0% | +15.9% | |
| 2014 | $70.35 | $90.40 | 0.0% | +28.5% | |
| 2013 | $49.20 | $70.35 | 0.0% | +43.0% | |
| 2012 | $34.38 | $49.20 | 0.0% | +43.1% | |
| 2011 | $26.93 | $34.38 | 0.0% | +27.7% | |
| 2010 | $18.81 | $26.93 | 0.0% | +43.2% | |
| 2009 | $17.80 | $18.81 | 0.0% | +5.7% | |
| 2008 | $35.40 | $17.80 | 0.0% | -49.7% | |
| 2007 | $16.39 | $35.40 | 0.0% | +116.0% | |
| 2006 | $10.78 | $16.39 | 0.0% | +52.0% | |
| 2005 | $6.39 | $10.78 | 0.0% | +68.7% | |
| 2004 | $7.76 | $6.39 | 0.0% | -17.7% | |
| 2003 | $7.05 | $7.76 | 0.0% | +10.1% | |
| 2002 | $13.44 | $7.05 | 0.0% | -47.5% | |
| 2001 | $9.69 | $13.44 | 0.0% | +38.7% | |
| 2000 | $11.75 | $9.69 | 0.0% | -17.6% |
- Annualized
- +5.9%
- 2000–2026
- Average year
- +12.1%
- 26 full years
- Best year
- +116.0%
- 2007
- Worst year
- -49.7%
- 2008
- Positive years
- 16/26
- 62% up
Annualized (CAGR)
+5.9%
2000–2026
Average year
+12.1%
26 full years
Best year
+116.0%
2007
Worst year
-49.7%
2008
Positive years
16/26
62% up
Total return by period#
Annual
-100%-50%0%50%100%
2000-18%'00
2001+39%
2002-48%'02
2003+10%
2004-18%'04
2005+69%
2006+52%'06
2007+116%
2008-50%'08
2009+5.7%
2010+43%'10
2011+28%
2012+43%'12
2013+43%
2014+29%'14
2015+16%
2016-21%'16
2017+7.6%
2018-4.5%'18
2019-0.7%
2020+3.7%'20
2021+0.75%
2022+17%'22
2023-6.8%
2024-32%'24
2025-9.6%
2026-3.8%'26
Methodology#
Total returns, dividends reinvested, measured on BMRN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is BioMarin Pharmaceutical Inc.'s average annual return?
- Since 2000, BioMarin Pharmaceutical Inc. (BMRN) has returned about 5.9% a year (the compound annual growth rate) and an average calendar-year return of 12.1%.
- What were BioMarin Pharmaceutical Inc.'s best and worst years?
- Over 2000–2026, the best year was 2007 (+116.0%) and the worst was 2008 (-49.7%).
- How often is BioMarin Pharmaceutical Inc. up in a year?
- 16 of the 26 full years since 2000 were positive — about 62% of the time.
More on BioMarin Pharmaceutical Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100